Gsk Share Discussion Threads

[jadeticl3] 12/3/2015 18:04

Deal? Or was it a Pharma correction as AZ also had a very good day?

[philanderer] 12/3/2015 17:59

Market liked that deal today :-)

[tompion] 12/3/2015 13:41

Yeah - just read in full and not quite as impressive protection by vaccine as suggested by the abstract of the article. About 80% of vaccinated animals survived a challenge infection with Staph. aureus. Paper is in Proceedings National Academy of Sciences but you won't be able to access yet as only available pre-publication to registered users.

[yogaboy] 12/3/2015 09:39

Tompion do you have the article reference please? Not my field but sounds like an interesting read. Thanks!

[tompion] 12/3/2015 08:59

Interesting paper published today in top scientific journal by Novartis showing they have a new vaccine that gives very impressive protection against S. aureus/MRSA infection in an animal model. Early days but looks very promising (this is my field). If I remember correctly the vaccine portfolio of Novartis goes to GSK.

[philanderer] 12/3/2015 08:56

12th march Deutsche 'hold'

reiterates

[tradermichael] 12/3/2015 08:17

By better understanding our bodies' electrical systems, GSK hopes to design technology small and smart enough to manipulate them and possibly conquer diseases from rheumatoid arthritis to asthma to diabetes.

"If we look 10 years out, we should have a number of tiny devices—we call them bioelectronic medicines, because they are medicines—that will be treating conditions we use molecular medicines for today," Kris Famm, head of GSK's bioelectronics research and development unit, said in a telephone interview. "We are quite convinced this can be a class of new therapies."


The technology GSK envisions, which is also known as electroceuticals, would involve implanting tiny devices on nerve bundles associated with specific organ functions. Its broadest applications are still years from the market, but Famm said he thinks the biology is becoming well-enough understood that the challenge becomes one of engineering: being able to miniaturize electronic devices enough to very specifically stimulate certain nerves, and do so in an autonomous way, detecting and reacting to problems in the body. The approach should be so specific it avoids the off-target side effects that can derail otherwise promising medicines, he said.

[toffeeman] 11/3/2015 07:54

What would be the point of there being more than one broker if they said the same thing!

[tradermichael] 11/3/2015 07:33

Both have time machines set in opposite directions

[philanderer] 10/3/2015 16:50

....couple more from the clever people ;-)

JP Morgan underweight tp 1250p
Barclays overweight tp 1690p

reiterations.

[philanderer] 10/3/2015 13:41

GlaxoSmithKline: Jefferies lifts target to 1550p from 1420p and reiterates hold

[anhar] 09/3/2015 10:07

I stick to large cap shares in my approach. That means mostly FTSE100 and a very few from the FTSE250.

[dragonsteeth] 09/3/2015 08:18

Some interesting posts on High Yield Portfolios, and GSK certainly has a good fit into that strategy. The best Boards I've seen for HYP shares is over on MotleyFool under "Investors Roundtable" and called " High Yield - HYP Practical" and "High Yield - Share Strategies"



and

[madengland] 09/3/2015 08:06

Nothing new..... GlaxoSmithKline has fired more than 100 staff in China for misconduct after an internal investigation into a corruption scandal.The pharmaceuticals giant, which was hit with a record fine of 3 billion yuan (£300 million) by a Chinese court in September 2014, said that it had taken action against staff who had broken its code of conduct and statement of values but declined to confirm exactly how many had been dismissed.The UK drugmaker was found guilty of bribing doctors to prescribe its medicines. In a statement the company said that it had tightened its monitoring of expenses claims and

[madengland] 09/3/2015 08:03

Given its not on an RNS from the company, can we assume it's not a huge scandal? Any ideas of the story?

[philo124] 09/3/2015 07:46

100 staff fired in China.

[madengland] 08/3/2015 15:12

Thanks, I will have a good trawl through. As I said I am just starting to build my portfolio of yielding stocks as I sell down a growth and take cash out my business. Some I have bought so far that may be of interest HICL (held a while), PEY, GCP. INFI looks interesting I will certainly have a good look at that. Best.

[tradermichael] 08/3/2015 11:09

I assume you hold those shares in an ISA?

[garycook] 08/3/2015 09:01

Madengland,I hold GSK and 27 other Income stocks yielding me 6.3%. For Value, yield and growth at the moment.ALY 28p(Yield 7%)Target price 32/35p.BEZ 280p(7.5%)TP 320p, CNA 242p(5.6%)TP 280/300p, HSD 88p(9%)TP 100p HGM 37p(13%)TP 50p Russian Gold Miner, Dividend could be cut the by 50%,HSBA 568p(5.7%) TP 660p,INFI Renewable Energy 190p(9.5%)TP 220/250P.So you have a Retailer,Speciality Insurer(BRIT and CGL just being taken over)Gas and Energy,Life Insurer/Asset Management.Gold Mining,Banking,and Renewable Energy average yield 7% assuming a 50% Dividend cut on HGM I own and hold for Dividend Income similar to anhar. Recently Sold AML,CGL.CWC,and purchased BEZ 279,INFI 199 and LRE FOR 5.67 now 6.60,but still a good buy for the minimum 8% Dividend with Special Divi with Finals every year,and ALY,BEZ,INFI,AND LRE are all possible take over targets,do your own research and good luck.I have a £445,000 Portfolio yielding me appox £28,000 a year.What stocks do you own at the moment?

[madengland] 08/3/2015 06:48

Any high yielders you are looking to add or increase holding? Am slowly trying to build a little income nest egg hence my interest in others approaches

[madengland] 08/3/2015 06:46

Thanks for sharing, always good to understand what's working for others and why. Especially as many pay fund managers unnecessary fees to deliver uncompelling returns.